- Report
- June 2023
- 186 Pages
Global
From €5303EUR$5,500USD£4,535GBP
- Report
- January 2024
- 150 Pages
Global
From €5736EUR$5,950USD£4,906GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- January 2024
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- December 2023
- 200 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- March 2024
- 140 Pages
Global
From €3759EUR$3,899USD£3,215GBP
- Report
- November 2023
- 146 Pages
Global
From €2409EUR$2,499USD£2,061GBP
- Report
- October 2023
- 181 Pages
Global
From €4724EUR$4,900USD£4,040GBP
- Report
- June 2022
- 283 Pages
United States
From €5062EUR$5,250USD£4,329GBP
- Report
- March 2022
- 278 Pages
Global
From €6893EUR$7,150USD£5,895GBP
- Report
- April 2023
- 135 Pages
Global
From €5303EUR$5,500USD£4,535GBP
- Report
- March 2021
- 216 Pages
Global
From €1326EUR$1,375USD£1,134GBP
€2651EUR$2,750USD£2,267GBP
- Report
- August 2020
- 144 Pages
Europe
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- August 2020
- 139 Pages
North America
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- June 2020
- 168 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- April 2021
- 121 Pages
Middle East, Africa
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- April 2021
- 116 Pages
From €2025EUR$2,100USD£1,732GBP
€2892EUR$3,000USD£2,474GBP
- Report
- April 2022
- 325 Pages
Global
From €3471EUR$3,600USD£2,968GBP
- Report
- August 2019
- 410 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,889USD£3,098GBP
Imaging biomarkers are a type of biomarker used to measure and monitor biological processes in the body. They are used to detect and diagnose diseases, assess the effectiveness of treatments, and monitor the progression of diseases. Imaging biomarkers are typically used in conjunction with other biomarkers, such as genetic and molecular biomarkers, to provide a more comprehensive picture of a patient's health. Imaging biomarkers can be used to detect changes in the structure and function of organs, tissues, and cells. Examples of imaging biomarkers include MRI, CT, PET, and ultrasound.
Imaging biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and radiology. They are also used in clinical trials to assess the safety and efficacy of new treatments. Imaging biomarkers are becoming increasingly important in the diagnosis and treatment of diseases, as they provide a more detailed picture of a patient's health.
Companies in the imaging biomarker market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Hitachi Medical Systems. Show Less Read more